X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1031) 1031
Book Chapter (210) 210
Conference Proceeding (21) 21
Newspaper Article (7) 7
Patent (4) 4
Publication (4) 4
Book / eBook (2) 2
Book Review (2) 2
Dissertation (2) 2
Magazine Article (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (499) 499
life sciences & biomedicine (331) 331
humans (180) 180
technology (135) 135
male (129) 129
female (124) 124
oncology (110) 110
middle aged (104) 104
analysis (103) 103
physical sciences (103) 103
adult (88) 88
aged (85) 85
melanoma (65) 65
chemistry (64) 64
melanoma - drug therapy (62) 62
materials science (59) 59
engineering (57) 57
iran (55) 55
aged, 80 and over (46) 46
treatment outcome (45) 45
cancer (42) 42
patients (38) 38
care and treatment (37) 37
immunotherapy (37) 37
clinical trials (35) 35
ipilimumab (35) 35
studies (35) 35
skin neoplasms - drug therapy (34) 34
surgery (34) 34
usage (34) 34
melanoma - pathology (33) 33
nanoparticles (33) 33
antineoplastic agents - therapeutic use (32) 32
otorhinolaryngology (31) 31
research (31) 31
general & internal medicine (30) 30
metastasis (30) 30
mutation (30) 30
medicine (29) 29
medicine, general & internal (29) 29
skin neoplasms - pathology (29) 29
young adult (29) 29
materials science, multidisciplinary (28) 28
adolescent (27) 27
antibodies, monoclonal - therapeutic use (27) 27
health aspects (27) 27
tumors (27) 27
original (26) 26
antibodies, monoclonal - adverse effects (25) 25
neoplasm staging (25) 25
original article (25) 25
medicine, research & experimental (24) 24
research & experimental medicine (24) 24
abridged index medicus (23) 23
algorithms (23) 23
environmental sciences & ecology (23) 23
immunology (23) 23
mathematical models (23) 23
prognosis (23) 23
science & technology - other topics (23) 23
animals (22) 22
environmental sciences (22) 22
antibodies, monoclonal - administration & dosage (20) 20
medical research (20) 20
melanoma - genetics (20) 20
neural networks (20) 20
pharmacology & pharmacy (20) 20
agriculture (19) 19
antineoplastic agents - adverse effects (19) 19
chemistry, physical (19) 19
disease-free survival (19) 19
methods (19) 19
proto-oncogene proteins b-raf - genetics (19) 19
mechanical properties (18) 18
retrospective studies (18) 18
drug therapy (17) 17
metallurgy & metallurgical engineering (17) 17
child (16) 16
engineering, chemical (16) 16
food science & technology (16) 16
investigations (16) 16
melanoma - secondary (16) 16
metastases (16) 16
nanocomposites (16) 16
physics (16) 16
research article (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
energy & fuels (15) 15
nanostructure (15) 15
neurosciences & neurology (15) 15
risk factors (15) 15
chemotherapy (14) 14
clinical neurology (14) 14
dentistry (14) 14
follow-up studies (14) 14
gene expression (14) 14
medicine & public health (14) 14
medicine, experimental (14) 14
melanoma - immunology (14) 14
nanopartikel (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1271) 1271
Persian (19) 19
Portuguese (4) 4
German (3) 3
French (2) 2
Chinese (1) 1
Dutch (1) 1
Italian (1) 1
Japanese (1) 1
Korean (1) 1
Polish (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of translational medicine, ISSN 1479-5876, 11/2011, Volume 9, Issue 1, pp. 204 - 204
Background: Ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in... 
Tumor biomarker | Cytotoxic t-lymphocyte antigen-4 | Tumor-infiltrating lymphocytes | Ipilimumab | Melanoma | Indoleamine 2,3-dioxygenase | Foxp3 | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunohistochemistry | Prospective Studies | Skin Neoplasms - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Young Adult | Antineoplastic Agents - adverse effects | Melanoma - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Skin Neoplasms - pathology | Tumor Microenvironment - drug effects | Drug Administration Schedule | Antibodies, Monoclonal - pharmacology | RNA, Messenger - genetics | Treatment Outcome | Melanoma - pathology | Polymorphism, Genetic | Antibodies, Monoclonal - administration & dosage | Melanoma - drug therapy | Skin Neoplasms - genetics | Aged | Neoplasm Staging | Usage | Messenger RNA | Physiological aspects | Genetic aspects | Research | Biological markers | Gene expression | Studies | Clinical trials | Medical research | Cancer | Index Medicus | ipilimumab | Cytotoxic T-lymphocyte antigen-4 | melanoma | tumor-infiltrating lymphocytes | indoleamine 2,3-dioxygenase | FoxP3 | tumor biomarker
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2015, Volume 372, Issue 26, pp. 2521 - 2532
Journal Article
Catena (Giessen), ISSN 0341-8162, 02/2016, Volume 137, pp. 360 - 372
Groundwater is considered as the most important natural resources in arid and semi-arid regions. In this study, the application of random forest (RF) and... 
GIS | Iran | Random forest (RF) | Mehran Region | Groundwater potential | Maximum entropy (ME) | Case studies | Water | Arid regions | Water, Underground | Models | Aquatic resources | Management | Geographic information systems
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2018, Volume 379, Issue 8, pp. 722 - 730
Journal Article